← SynDRA
RASAGILINE
SynDRA canonical compound SYN0002419 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | MAOB |
|---|
| Mechanism of action | Monoamine oxidase inhibitor |
|---|
| Indication | Parkinson's Disease |
|---|
| Disease area | neurology/psychiatry |
|---|
All known targets
- MAOB
- ACHE
- BCHE
- BCL2
- HTR6
- MAOA
- Maoa
- Maob
Mechanisms of action (all sources)
- Monoamine oxidase inhibitor
- MAOB INHIBITOR
- Monoamine oxidase B inhibitor
Drug classes
- Monoamine Oxidase Inhibitors
- Central Nervous System Agents
- Enzyme Inhibitors
- Neuroprotective Agents
- Protective Agents
- Monoamine Oxidase Inhibitor
ATC classes
- N04B · DOPAMINERGIC AGENTS
Cross-references
Synonyms
- TVP-1022
- rasagiline hydrochloride
- azilect
- (R)-(+)-Rasagiline
- rasagiline mesylate
- TV-1030
- rasagiline mesilate
- Rasagilina
- AGN-1135
- NSC-759639
- RAS
- Rasagiline [INN]
- Azilect (TN)
- Rasagiline (INN)
- (1R)-N-(prop-2-yn-1-yl)-2,3-dihydro-1H-inden-1-amine
- (1R)-N-prop-2-ynyl-2,3-dihydro-1H-inden-1-amine
- (R)-N-2-Propynyl-1-indanamine
- 1H-Inden-1-amine, 2,3-dihydro-N-2-propynyl-, (1R)
- 1H-Inden-1-amine, 2,3-dihydro-N-2-propynyl-, (1R)-
- 1H-INDEN-1-AMINE, 2,3-DIHYDRO-N-2-PROPYN-1-YL-, (1R)-
- 1H-INDEN-1-AMINE, 2,3-DIHYDRO-N-2-PROPYNYL-, (R)-
- (1R)-2,3-DIHYDRO-N-2-PROPYN-1-YL-1H-INDEN-1-AMINE
- Agn-1135
- TV 1030
- NSC 759639
- (1R)-N-propargylindan-1-amine
- (R)-Indan-1-yl-prop-2-ynyl-amine
- CHEBI:63620
- rasagilinum
- TVP-101
- RefChem:875177
- DTXCID1021112
- N04BD02
- N-2-propynyl-1-indanamine
- TVP1022
- (R)-N-(2-Propynyl)-2,3-dihydroinden-1-amine
- MFCD00866571
- 1-Indanamine, N-2-propynyl-, (R)-
Reported adverse events
- Abdominal pain
- Abnormal dreams
- Arthralgia
- Arthritis
- Conjunctivitis
- Constipation
- Depression
- Dry mouth
- Dyskinesia
- Dystonia
- Fall
- Hallucination
Look up RASAGILINE in the interactive SynDRA portal →